These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 15158783)
1. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives. Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and analgesic profile of conformationally constrained N-acylhydrazone analogues: discovery of novel N-arylideneamino quinazolin-4(3H)-one compounds derived from natural safrole. Maia RC; Silva LL; Mazzeu EF; Fumian MM; de Rezende CM; Doriguetto AC; Corrêa RS; Miranda AL; Barreiro EJ; Fraga CA Bioorg Med Chem; 2009 Sep; 17(18):6517-25. PubMed ID: 19699644 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 3,4-methylenedioxy-6-nitrophenoxyacetylhydrazone derivatives obtained from natural safrole: new lead-agents with analgesic and antipyretic properties. Bezerra-Netto HJ; Lacerda DI; Miranda AL; Alves HM; Barreiro EJ; Fraga CA Bioorg Med Chem; 2006 Dec; 14(23):7924-35. PubMed ID: 16904329 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-platelet activity of novel arylsulfonate--acylhydrazone derivatives, designed as antithrombotic candidates. Lima LM; Frattani FS; Dos Santos JL; Castro HC; Fraga CA; Zingali RB; Barreiro EJ Eur J Med Chem; 2008 Feb; 43(2):348-56. PubMed ID: 17532545 [TBL] [Abstract][Full Text] [Related]
5. Discovery of new orally effective analgesic and anti-inflammatory hybrid furoxanyl N-acylhydrazone derivatives. Hernández P; Cabrera M; Lavaggi ML; Celano L; Tiscornia I; Rodrigues da Costa T; Thomson L; Bollati-Fogolín M; Miranda AL; Lima LM; Barreiro EJ; González M; Cerecetto H Bioorg Med Chem; 2012 Mar; 20(6):2158-71. PubMed ID: 22356737 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and analgesic-antiinflammatory activities of novel acylarylhydrazones with a 5-phenyl-4-R-3-pyrrolyl-acyl moiety. Murineddu G; Loriga G; Gavini E; Peana AT; Mulè AC; Pinna GA Arch Pharm (Weinheim); 2001 Dec; 334(12):393-8. PubMed ID: 11852535 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of pyrazine N-acylhydrazone derivatives designed as novel analgesic and anti-inflammatory drug candidates. da Silva YK; Augusto CV; de Castro Barbosa ML; de Albuquerque Melo GM; de Queiroz AC; de Lima Matos Freire Dias T; Júnior WB; Barreiro EJ; Lima LM; Alexandre-Moreira MS Bioorg Med Chem; 2010 Jul; 18(14):5007-15. PubMed ID: 20598893 [TBL] [Abstract][Full Text] [Related]
9. Antiplatelet properties of novel N-substituted-phenyl-1,2,3-triazole-4-acylhydrazone derivatives. Cunha AC; Figueiredo JM; Tributino JL; Miranda AL; Castro HC; Zingali RB; Fraga CA; de Souza MC; Ferreira VF; Barreiro EJ Bioorg Med Chem; 2003 May; 11(9):2051-9. PubMed ID: 12670656 [TBL] [Abstract][Full Text] [Related]
10. Novel furfurylidene N-acylhydrazones derived from natural safrole: discovery of LASSBio-1215, a new potent antiplatelet prototype. Rodrigues AP; Costa LM; Santos BL; Maia RC; Miranda AL; Barreiro EJ; Fraga CA J Enzyme Inhib Med Chem; 2012 Feb; 27(1):101-9. PubMed ID: 21612374 [TBL] [Abstract][Full Text] [Related]
11. Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2-a]pyridine symbiotic prototypes. Lacerda RB; de Lima CK; da Silva LL; Romeiro NC; Miranda AL; Barreiro EJ; Fraga CA Bioorg Med Chem; 2009 Jan; 17(1):74-84. PubMed ID: 19059783 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiplatelet activity of new imidazole-4-carboxylic acid derivatives. Rehse K; Steege J Arch Pharm (Weinheim); 2005 Nov; 338(11):539-47. PubMed ID: 16281307 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity. Wang WY; Hsieh PW; Wu YC; Wu CC Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492 [TBL] [Abstract][Full Text] [Related]
14. The evaluation and structure-activity relationships of 2-benzoylaminobenzoic esters and their analogues as anti-inflammatory and anti-platelet aggregation agents. Hsieh PW; Hwang TL; Wu CC; Chiang SZ; Wu CI; Wu YC Bioorg Med Chem Lett; 2007 Mar; 17(6):1812-7. PubMed ID: 17197180 [TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological evaluation of novel antinociceptive N-substituted-phenylimidazolyl-4-acylhydrazone derivatives. Cunha AC; Tributino JL; Miranda AL; Fraga CA; Barreiro EJ Farmaco; 2002 Dec; 57(12):999-1007. PubMed ID: 12564475 [TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs. Fraga CA; Barreiro EJ Curr Med Chem; 2006; 13(2):167-98. PubMed ID: 16472212 [TBL] [Abstract][Full Text] [Related]
18. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives. Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of linear 1-(4-, 3- or 2-methylsulfonylphenyl)-2-phenylacetylenes: a novel class of cyclooxygenase-2 inhibitors. Chen QH; Rao PN; Knaus EE Bioorg Med Chem; 2005 Dec; 13(23):6425-34. PubMed ID: 16099663 [TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of 3-alkyl-2-aryl-1,3-thiazinan-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors. Zebardast T; Zarghi A; Daraie B; Hedayati M; Dadrass OG Bioorg Med Chem Lett; 2009 Jun; 19(12):3162-5. PubMed ID: 19447036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]